BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 19762530)

  • 21. CDX-2 Expression in Primary Lung Adenocarcinoma.
    Cowan ML; Li QK; Illei PB
    Appl Immunohistochem Mol Morphol; 2016 Jan; 24(1):16-9. PubMed ID: 26469326
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Immunohistochemical profile of colorectal and ovarian carcinomas--examination with cytokeratin 7, cytokeratin 20, beta catenin and cDX 2].
    Porjazova E; Zaprjanov Z; Batashki I; Markova D; Milchev N
    Akush Ginekol (Sofiia); 2009; 48(2):7-12. PubMed ID: 20198769
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Intestinal type and endocervical-like ovarian mucinous neoplasms are immunophenotypically distinct entities.
    Lin X; Lindner JL; Silverman JF; Liu Y
    Appl Immunohistochem Mol Morphol; 2008 Oct; 16(5):453-8. PubMed ID: 18665037
    [TBL] [Abstract][Full Text] [Related]  

  • 24. CDX-2 expression in pseudomyxoma peritonei: a clinicopathological study of 42 cases.
    Nonaka D; Kusamura S; Baratti D; Casali P; Younan R; Deraco M
    Histopathology; 2006 Oct; 49(4):381-7. PubMed ID: 16978201
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Ovarian mucinous tumors associated with mature cystic teratomas: morphologic and immunohistochemical analysis identifies a subset of potential teratomatous origin that shares features of lower gastrointestinal tract mucinous tumors more commonly encountered as secondary tumors in the ovary.
    Vang R; Gown AM; Zhao C; Barry TS; Isacson C; Richardson MS; Ronnett BM
    Am J Surg Pathol; 2007 Jun; 31(6):854-69. PubMed ID: 17527072
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Usefulness of Cdx2 in separating mucinous bronchioloalveolar adenocarcinoma of the lung from metastatic mucinous colorectal adenocarcinoma.
    Saad RS; Cho P; Silverman JF; Liu Y
    Am J Clin Pathol; 2004 Sep; 122(3):421-7. PubMed ID: 15362373
    [TBL] [Abstract][Full Text] [Related]  

  • 27. PDX-1, CDX-2, TTF-1, and CK7: a reliable immunohistochemical panel for pancreatic neuroendocrine neoplasms.
    Chan ES; Alexander J; Swanson PE; Jain D; Yeh MM
    Am J Surg Pathol; 2012 May; 36(5):737-43. PubMed ID: 22498824
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Among sinonasal tumors, CDX-2 immunoexpression is not restricted to intestinal-type adenocarcinomas.
    Tilson MP; Gallia GL; Bishop JA
    Head Neck Pathol; 2014 Mar; 8(1):59-65. PubMed ID: 23846317
    [TBL] [Abstract][Full Text] [Related]  

  • 29. P16(INK4a) protein expression in endocervical, endometrial and metastatic adenocarcinomas of extra-uterine origin: diagnostic and clinical considerations.
    Caponio MA; Addati T; Popescu O; Petroni S; Rubini V; Centrone M; Trojano G; Simone G
    Cancer Biomark; 2014; 14(2-3):169-75. PubMed ID: 24878818
    [TBL] [Abstract][Full Text] [Related]  

  • 30. CK7, CK20, CDX2 and MUC2 Immunohistochemical staining used to distinguish metastatic colorectal carcinoma involving ovary from primary ovarian mucinous adenocarcinoma.
    Shin JH; Bae JH; Lee A; Jung CK; Yim HW; Park JS; Lee KY
    Jpn J Clin Oncol; 2010 Mar; 40(3):208-13. PubMed ID: 19926591
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Utility of p16 expression for distinction of uterine serous carcinomas from endometrial endometrioid and endocervical adenocarcinomas: immunohistochemical analysis of 201 cases.
    Yemelyanova A; Ji H; Shih IeM; Wang TL; Wu LS; Ronnett BM
    Am J Surg Pathol; 2009 Oct; 33(10):1504-14. PubMed ID: 19623034
    [TBL] [Abstract][Full Text] [Related]  

  • 32. No metastatic cervical adenocarcinomas in a series of p16INK4a-positive mucinous or endometrioid advanced ovarian carcinomas: an analysis of the AGO Ovarian Cancer Study Group.
    Wentzensen N; du Bois A; Kommoss S; Pfisterer J; von Knebel Doeberitz M; Schmidt D; Kommoss F
    Int J Gynecol Pathol; 2008 Jan; 27(1):18-23. PubMed ID: 18156969
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Primary mucinous (so-called colloid) carcinomas of the lung: a clinicopathologic and immunohistochemical study with special reference to CDX-2 homeobox gene and MUC2 expression.
    Rossi G; Murer B; Cavazza A; Losi L; Natali P; Marchioni A; Migaldi M; Capitanio G; Brambilla E
    Am J Surg Pathol; 2004 Apr; 28(4):442-52. PubMed ID: 15087663
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Alteration of cytokeratin 7 and cytokeratin 20 expression profile is uniquely associated with tumorigenesis of primary adenocarcinoma of the small intestine.
    Chen ZM; Wang HL
    Am J Surg Pathol; 2004 Oct; 28(10):1352-9. PubMed ID: 15371952
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Cdx2, cytokeratin 20, thyroid transcription factor 1, and prostate-specific antigen expression in unusual subtypes of prostate cancer.
    Leite KRM; Mitteldorf CATS; Srougi M; Dall'Oglio MF; Antunes AA; Pontes J; Camara-Lopes LH
    Ann Diagn Pathol; 2008 Aug; 12(4):260-266. PubMed ID: 18620992
    [TBL] [Abstract][Full Text] [Related]  

  • 36. P16INK4a expression in undifferentiated carcinoma of the uterus does not exclude its endometrial origin.
    Saad RS; Mashhour M; Noftech-Mozes S; Ismiil N; Dubé V; Ghorab Z; Faragalla H; Khalifa MA
    Int J Gynecol Pathol; 2012 Jan; 31(1):57-65. PubMed ID: 22123724
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Detection of CDX-2, CK7 and CK20 in primary and metastatic ovarian carcinoma].
    Yuan ZF; Shi HR; Sun HM; Li WC
    Zhonghua Bing Li Xue Za Zhi; 2007 Aug; 36(8):555-6. PubMed ID: 17980105
    [No Abstract]   [Full Text] [Related]  

  • 38. Distinctive immunohistochemical profile of mucinous cystic neoplasms of pancreas, ovary and lung.
    Silverman JF; Zhu B; Liu Y; Lin X
    Histol Histopathol; 2009 Jan; 24(1):77-82. PubMed ID: 19012247
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Expression of REG4 in ovarian mucinous tumors.
    Huang Q; Chen X; Lu W; Lai M; Lu B
    Appl Immunohistochem Mol Morphol; 2014 Apr; 22(4):295-301. PubMed ID: 23958547
    [TBL] [Abstract][Full Text] [Related]  

  • 40. CDX-2 homeobox gene expression is a reliable marker of colorectal adenocarcinoma metastases to the lungs.
    Barbareschi M; Murer B; Colby TV; Chilosi M; Macri E; Loda M; Doglioni C
    Am J Surg Pathol; 2003 Feb; 27(2):141-9. PubMed ID: 12548159
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.